Skip to main content
//empty //empty

Manulife joint venture in China faced whistle-blower complaints: In late July, 2017, the first in a series of bank transactions moved money out of the personal accounts of several insurance executives to an account belonging to Manulife-Sinochem Life Insurance Co. Ltd. (Nathan VanderKlippe)

Canada’s big banks resume advertising with Facebook after one month boycott: Canada’s major banks have resumed buying ads on Facebook after halting spending in July in an effort to press the social-media company to do more to stamp out hate speech and misinformation on its sites. (James Bradshaw)

Rival Torstar bidder drops court appeal to NordStar takeover: A rival bidder for Torstar Corp. has dropped its legal challenge to a $60-million takeover of the publishing company, allowing NordStar Capital LP to complete its friendly deal after weeks of heated sparring. (Jeffrey Jones)

Story continues below advertisement

Great-West Lifeco to sell Canadian subsidiary for $175-million to Mackenzie: Great-West Lifeco Inc. says it is selling its Canadian subsidiary GLC Asset Management Group Ltd. to Mackenzie Financial Corp. for $175-million in cash. (The Canadian Press)

Bausch to pay $94-million plus costs to resolve Canadian securities class action: Bausch Health Cos. Inc. says it is ending significant legal matters from the Valeant era by agreeing to pay $94-million plus administration costs to resolve a Canadian securities class action. (The Canadian Press)

The Streetwise newsletter is Monday to Friday. If you’re reading this on the web, or if someone forwarded this e-mail to you, you can sign up for Streetwise and all Globe newsletters on our signup page.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies